Intraoperative indocyanine green fluorescence guidance for excision of nonpalpable breast cancer
- PMID: 27756411
- PMCID: PMC5070155
- DOI: 10.1186/s12957-016-1014-2
Intraoperative indocyanine green fluorescence guidance for excision of nonpalpable breast cancer
Abstract
Background: Different techniques have been used for the guidance of nonpalpable breast cancer (NBC), but none of them has yet achieved perfect results. The aim of this study was to evaluate the feasibility of indocyanine green (ICG) fluorescence-guided nonpalpable breast cancer lesion excision (IFNLE), to introduce an alternative technique.
Methods: The data about 56 patients with preoperatively diagnosed NBCs operated with the help of intraoperative IFNLE between November of 2010 and September of 2014 were retrospectively analyzed.
Results: ICG fluorescence localized all lesions at surgery. Re-excision due to positive resection margins was necessary in two patients (3.6 %; 2/56) with ductal carcinoma in situ (DCIS) at the surgical margins. Mastectomy was necessary in one patient (1.8 %; 1/56) due to multifocal invasive carcinoma. The mean volume of the excised tissue was 38.2 ± 16.5 cm3.
Conclusions: IFNLE is a technically applicable and clinically acceptable procedure whenever a breast cancer needs image-guided excision.
Keywords: Indocyanine green fluorescence imaging; Intraoperative excision; Nonpalpable breast cancer.
Figures



Similar articles
-
Indocyanine green fluorescence-guided lumpectomy of nonpalpable breast cancer versus wire-guided excision: A randomized clinical trial.Breast J. 2019 Mar;25(2):278-281. doi: 10.1111/tbj.13207. Epub 2019 Feb 22. Breast J. 2019. PMID: 30801900 Clinical Trial.
-
Low re-excision rate for positive margins in patients treated with ultrasound-guided breast-conserving surgery.Breast. 2013 Oct;22(5):698-702. doi: 10.1016/j.breast.2012.12.019. Epub 2013 Jan 17. Breast. 2013. PMID: 23333255
-
Radioactive seed localization of nonpalpable breast lesions in an academic comprehensive cancer program community hospital setting.Am Surg. 2014 Jul;80(7):675-9. Am Surg. 2014. PMID: 24987899
-
Surgical treatment of nonpalpable primary invasive and in situ breast cancer.Nat Rev Clin Oncol. 2015 Nov;12(11):645-63. doi: 10.1038/nrclinonc.2015.161. Epub 2015 Sep 29. Nat Rev Clin Oncol. 2015. PMID: 26416152 Review.
-
Breast MRI in DCIS size estimation, breast-conserving surgery and oncoplastic breast surgery.Cancer Treat Rev. 2021 Mar;94:102158. doi: 10.1016/j.ctrv.2021.102158. Epub 2021 Feb 2. Cancer Treat Rev. 2021. PMID: 33610127 Review.
Cited by
-
Optimizing fresh specimen staining for rapid identification of tumor biomarkers during surgery.Theranostics. 2017 Oct 17;7(19):4722-4734. doi: 10.7150/thno.21527. eCollection 2017. Theranostics. 2017. PMID: 29187899 Free PMC article.
-
Fluorescence guided surgery imaging systems for breast cancer identification: a systematic review.J Biomed Opt. 2024 Mar;29(3):030901. doi: 10.1117/1.JBO.29.3.030901. Epub 2024 Mar 4. J Biomed Opt. 2024. PMID: 38440101 Free PMC article.
-
Optical imaging guidance in oncologic surgery and interventional oncology.Pharmacol Res. 2025 Feb;212:107612. doi: 10.1016/j.phrs.2025.107612. Epub 2025 Jan 17. Pharmacol Res. 2025. PMID: 39826822 Free PMC article. Review.
-
L-ICG as an optical agent to improve intraoperative margin detection in breast-conserving surgery: a prospective study.Breast Cancer Res Treat. 2025 Apr;210(3):709-718. doi: 10.1007/s10549-025-07609-6. Epub 2025 Jan 20. Breast Cancer Res Treat. 2025. PMID: 39832050
-
Efficacy of indocyanine green fluorescence for the identification of non-palpable breast tumours: systematic review.BJS Open. 2023 Sep 5;7(5):zrad092. doi: 10.1093/bjsopen/zrad092. BJS Open. 2023. PMID: 37751322 Free PMC article.
References
-
- Tabar L, Dean PB, Kaufman CS, Duffy SW, Chen HH. A new era in the diagnosis of breast cancer. Surg Oncol Clin North Am. 2000;9:233–7. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical